Condition: Elevated Lp(a) · Atherosclerotic Cardiovascular Disease (ASCVD) · Sponsor: Eli Lilly and Company
The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Smiths Medical Center | Apache Junction, Arizona, United States | Not Yet Recruiting |
| Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC | Gilbert, Arizona, United States | Recruiting |
| Axsendo Clinical Research - Peak Heart & Vascular - Phoenix | Phoenix, Arizona, United States | Recruiting |
| Clinical Research Institute of Arizona (CRI) - Sun City West | Sun City West, Arizona, United States | Recruiting |
| Southwest Kidney Institute - Surprise | Surprise, Arizona, United States | Recruiting |
| Pima Heart | Tucson, Arizona, United States | Recruiting |
| National Heart Institute | Beverly Hills, California, United States | Recruiting |
| John Muir Medical Center - Concord Campus | Concord, California, United States | Recruiting |
| Neighborhood Healthcare Institute of Health | Escondido, California, United States | Recruiting |
| Ark Clinical Research - Fountain Valley | Fountain Valley, California, United States | Recruiting |
| Care Access - Huntington Beach | Huntington Beach, California, United States | Recruiting |
| Scripps Whittier Diabetes Institute | La Jolla, California, United States | Not Yet Recruiting |
+ 760 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07157774